Branched Motifs Enable Long-Range Interactions in Signaling Networks through Retrograde Propagation

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Jesan, Tharmaraj ^a,b   Sarma, Uddipan ^c   Halder, Subhadra ^c   Saha, Bhaskar ^c   Sinha, Sitabhra ^a  

^a INSTITUTE OF MATHEMATICAL SCIENCES   (India)

^b BHABHA ATOMIC RESEARCH CENTRE   (India)

^c NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; T LYMPHOCYTE RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE COMPLEX; IMMUNE RESPONSE; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN STRUCTURE;

ANIMALS; ANTHRACENES; FEEDBACK, PHYSIOLOGICAL; GENE EXPRESSION REGULATION; IMIDAZOLES; MACROPHAGES, PERITONEAL; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; MICE; MODELS, BIOLOGICAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE INHIBITORS; PYRIDINES;

EID: 84878589736     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064409     Document Type: Article

References (49)

1. Hartwell LH, Hopfield JJ, Leibler S, Murray AW, (1999) From molecular to modular cell biology. Nature 402: C47-52.
2. Seger R, Krebs EG, (1995) The MAPK signaling cascade. FASEB Journal 9: 726-735.
3. Widmann C, Gibson S, Jarpe MB, Johnson GL, (1999) Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human. Physiol Rev 79: 143-180.
4. Kolch W, (2000) Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochemical Journal 351: 289-305.
5. Orton RJ, Sturm OE, Vyshemirsky V, Calder M, Gilbert DR, et al. (2005) Computational modelling of the receptor-tyrosine-kinase-activated MAPK pathway. Biochemical Journal 392: 249-261.
6. Lewin B, Cassimeris L, Lingappa VR, Plopper G, editors (2007) Cells (Jones and Bartlett, Sudbury, MA).
7. Fanger GR, Widmann C, Porter AC, Sather S, Johnson GL, et al. (1998) 14-3-3 proteins interact with specific MEK kinase. J Biol Chem 273: 3476-3483.
8. Huse M, (2009) The T-cell receptor signaling network. J Cell Science 122: 1269-1273.
9. Dal Porto JM, Gauld SB, Merrell KT, Mills D, Pugh-Bernard AE, et al. (2004) B cell antigen receptor signaling 101. Mol Immunol 41: 599-613.
10. Weng G, Bhalla US, Iyengar R, (1999) Complexity in biological signaling systems. Science 284: 92-96.
11. Downward J, (2001) The ins and outs of signalling. Nature 411: 759-762.
12. Komarova NL, Zou X, Nie Q, Bardwell L, (2005) A theoretical framework for specificity in cell signaling. Mol Sys Biol 1: 0023.
13. Qiao L, Nachbar RB, Kevrekidis IG, Shvartsman SY, (2007) Bistability and oscillations in the Huang-Ferrell model of MAPK signaling. PLoS Comput Biol 3: e184.
14. Ventura AC, Sepulchre JA, Merajver SD, (2008) A hidden feedback in signaling cascades is revealed. PLoS Comput Biol 4: e1000041.
15. Lange-Carter CA, Pleiman CM, Gardner AM, Blumer KJ, Johnson GL, (1993) A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science 260: 315-319.
16. Yan M, Dai T, Deak JC, Kyriakis JM, Zon LI, et al. (1995) Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1. Nature 372: 798-800.
17. Lu X, Nemoto S, Lin A, (1997) Identification of c-Jun NH2-terminal protein kinase (JNK)-activating kinase 2 as an activator of JNK but not p38. J Biol Chem 272: 24751-4.
18. Deacon K, Blank JL, (1997) Characterization of the mitogen-activated protein kinase kinase 4 (MKK4)/c-Jun NH2-terminal kinase 1 and MKK3/p38 pathways regulated by MEK kinases 2 and 3. MEK kinase 3 activates MKK3 but does not cause activation of p38 kinase in vivo. J Biol Chem 30: 14489-96.
19. Deacon K, Blank JL, (1999) MEK kinase 3 directly activates MKK6 and MKK7, specific activators of the p38 and c-Jun NH2-terminal kinases. J Biol Chem 274: 16604-16610.
20. Abell AN, Granger DA, Johnson GL, (2007) MEKK4 stimulation of p38 and JNK activity is negatively regulated by GSK3β. J Biol Chem 282: 30476-30484.
21. Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, et al. (1997) Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signalling pathways. Science 275: 90-94.
22. Zama T, Aoki R, Kamimoto T, Inoue K, Ikeda Y, et al. (2002) Scaffold role of a mitogen activated protein kinase phosphatase, SKRP1, for the JNK signaling pathway. J Biol Chem 277: 23919-23926.
23. Sutherland CL, Heath AW, Pelech SL, Young PR, Gold MR, (1996) Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor. J Immunol 157: 3381-3390.
24. Blüthgen N, Bruggeman FJ, Legewie S, Herzel H, Westerhoff HV, et al. (2006) Effects of sequestration on signal transduction cascades. FEBS Journal 273: 895-906.
25. Markevich NI, Hoek JB, Kholodenko BN, (2004) Signaling switches and bistability arising from multisite phosphorylation in protein kinase cascades. J Cell Biol 164: 353-359.
26. Fritsche-Guenther R, Witzel F, Sieber A, Herr R, Schmidt N, et al. (2011) Strong negative feedback from Erk to Raf confers robustness to MAPK signalling. Mol Sys Bio 7: 489.
27. Millat T, Bullinger E, Rohwer J, Wolkenhauer O, (2007) Approximations and their consequences for dynamic modelling of signal transduction pathways. Math Biosci 207: 40-57.
28. Cloutier M, Wang E, (2011) Dynamic modeling and analysis of cancer cellular network motifs. Integr Biol 3: 724-732.
29. Alon U, Surette MG, Barkai N, Leibler S, (1999) Robustness in bacterial chemotaxis. Nature 397: 168-171.
30. Soyer OS, Salathe M, Bonhoeffer M, (2006) Signal transduction networks: Topology, response and biochemical processes. J Theor Biol 238: 416-425.
31. Shin SY, Rath O, Choo SM, Fee F, McFerran B, et al. (2009) Positive- and negativefeedback regulations coordinate the dynamic behavior of the Ras-Raf-MEK-ERK signal transduction pathway. J Cell Sci 122: 425-435.
32. Olson JM, Hallahan AR, (2004) p38 MAP kinase: a convergence point in cancer therapy. Trends Mol Med 10: 125-129.
33. Lawrence MC, Jivan A, Shao C, Duan L, Goad D, et al. (2008) The roles of MAPKs in disease. Cell Res 18: 436-442.
34. Kim EK, Choi EJ, (2010) Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta 1802: 396-405.
35. Berger SI, Iyengar R, (2009) Network analyses in systems pharmacology. Bioinformatics 25: 2466-2472.
36. Wagner EF, Nebreda AR, (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9: 537-549.
37. Hagemann D, Troppmair J, Rapp UR, (1999) Cot protooncoprotein activates the dual specificity kinases MEK-1 and SEK-1 and induces differentiation of PC12 cells. Oncogene 18: 1391-1400.
38. Gantke T, Sriskantharajah S, Sadowski M, Ley SC, (2012) IkB kinase regulation of the TPL-2/ERK MAPK pathway. Immunol Rev 246: 168-182.
39. Hui L, Bakiri L, Mairhorfer A, Schweifer N, Haslinger C, et al. (2007) p38alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway. Nat Genet 39: 741-749.
40. Bennett BL, Satoh Y, Lewis AJ, (2003) JNK: a new therapeutic target for diabetes. Curr Opin Pharmacol 3: 420-425.
41. de Alvaro C, Teruel T, Hernandez R, Lorenzo M, (2004) Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPKdependent manner. J Biol Chem 279: 17070-17078.
42. Chowdhury TA, (2010) Diabetes and cancer. QJM 103: 905-915.
43. Rung J, Cauchi S, Albrechtsen A, Shen L, Rocheleau G, et al. (2009) Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat Genet 41: 1110-1115.
44. Knox C, Law V, Jewison T, Liu P, Ly S, et al. (2011) DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res 39: D1035-1041.
45. Huang CY, Ferrell JE, (1996) Ultrasensitivity in the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 93: 10078-10083.
46. Mathur RK, Awasthi A, Wadhone P, Ramanamurthy B, Saha B, (2004) Reciprocal CD40 signals through p38MAPK and ERK-1/2 induce counteracting immune responses. Nat Med 10: 540-544.
47. Rub A, Dey R, Jadhav M, Kamat R, Chakkaramakkil S, et al. (2009) Cholesterol depletion associated with Leishmania major infection alters macrophage CD40 signalosome composition and effector function. Nat Immunol 10: 273-280.
48. Srivastava N, Sudan R, Saha B, (2011) CD40-Modulated Dual-Specificity Phosphatases MAPK Phosphatase (MKP)-1 and MKP-3 Reciprocally Regulate Leishmania major Infection. J Immunol 186: 5863-5872.
49. Sudan R, Srivastava N, Pandey SP, Majumdar S, Saha B, (2012) Reciprocal regulation of protein kinase C isoforms results in differential cellular responsiveness. J Immunol 188: 2328-2337.